FDA advisory panel votes against psychedelic therapy to treat PTSD
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
Stay updated with breaking news from Healing Breakthrough. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
Panelists said they believe MDMA-assisted therapy is effective, but outstanding questions gave them pause in recommending its use to treat PTSD.
The VA is seeking “definitive scientific evidence on the potential efficacy and safety of psychedelic compounds” such as MDMA and psilocybin to treat PTSD.
The FDA wants to conclude its evaluation of MDMA-assisted therapy by Aug. 11.